Skip to main content
Rizobacter Argentina S.A. logo

Rizobacter Argentina S.A. — Investor Relations & Filings

ISIN · AR0065093756 BYMA Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2020-01-30 Capital/Financing Update
Country AR Argentina
Listing BYMA

About Rizobacter Argentina S.A.

https://rizobacter.com.ar/en/argentina

Rizobacter is a leading agricultural biosolutions company that researches, develops, and commercializes innovative products for sustainable crop growth. Specializing in biologicals, its comprehensive portfolio includes inoculants, biostimulants, seed treatments, adjuvants, biocontrol agents, and crop nutrition solutions. Notably, Rizobacter is a global leader in soybean inoculants. The company's sustainable biological solutions enhance crop productivity, drive higher yields, and contribute to global food security, leveraging a unique biotech platform with patented technologies for microbial ag-inputs.

Recent filings

Filing Released Lang Actions
FEC. CELEB.: 20-01-2020 - TEMA: TEMAS VARIOS - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Capital/Financing Update Classification · 80% confidence The document is the minutes of a Board of Directors meeting (Acta No. 362) of Rizobacter Argentina S.A., where the board resolves the subdelegation of powers to directors and managers to prepare and finalize the prospectus and conditions for issuing Series II negotiable obligations. This is a corporate financing resolution authorizing a debt issuance program. It therefore falls under “Capital/Financing Update” (CAP).
2020-01-30 Spanish
RELAC.: CONTROLADA - CUIT: U74999HR2016PTC065822 - RIZOBACTER INDIA PRIVATE LIMITED - FECH. CIERRE BAL.: 30-06-2019 - NORMA CONT.: OTROS - PERIODO BAL.: ANUAL - TIPO BAL.: INDIVIDUAL - ESTADOS CONTABL
Annual Report Classification · 95% confidence The document is titled as an "UNAUDITED BALANCE SHEET AS ON 30th JUNE, 2019" and includes a statement of profit and loss for the year ended 30th June 2019. It contains detailed financial statements including balance sheet, profit and loss account, notes on accounting policies, fixed assets, shareholders' funds, liabilities, assets, and expenses. The document is comprehensive and contains actual financial data and analysis for a full fiscal year. There is no indication that this is merely an announcement or a certification. The document fits the definition of an Annual Report (10-K) as it covers company activity and full financial performance for the year ended 30th June 2019. FY 2019
2020-01-30 Spanish
FEC. CELEB.: 23-12-2019 - TEMA: TEMAS VARIOS - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2020-01-07 Spanish
FEC. CELEB.: 22-07-2016 - TEMA: TEMAS VARIOS - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2019-12-17 Spanish
RELAC.: CONTROLADA - CUIT: 02.517482/000187 - RIZOBACTER DO BRASIL LTDA - FECH. CIERRE BAL.: 30-09-2019 - NORMA CONT.: NIIF - PERIODO BAL.: TRIMESTRAL - TIPO BAL.: INDIVIDUAL - ESTADOS CONTABLES - CON
Interim / Quarterly Report Classification · 100% confidence The document is titled as "Estados Financieros Especiales" (Special Financial Statements) for the three-month period from July 1, 2019, to September 30, 2019, presented comparatively. It contains detailed financial statements including balance sheets, income statements, cash flow statements, and notes to the financial statements. The document explicitly states it is prepared according to NIC 34 (International Accounting Standard for Interim Financial Reporting), indicating it is an interim financial report. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-11-15 Spanish
RELAC.: CONTROLADA - CUIT: 47-2016286 - RIZOBACTER USA LLC - FECH. CIERRE BAL.: 30-09-2019 - NORMA CONT.: NIIF - PERIODO BAL.: TRIMESTRAL - TIPO BAL.: INDIVIDUAL - ESTADOS CONTABLES - CONTROLADAS Y VI
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial statements for Rizobacter USA LLC for the three-month period ended September 30, 2019, including balance sheets, income statements, cash flow statements, and notes to the financial statements. It references preparation according to IAS 34 (Interim Financial Reporting) and includes substantive financial data and analysis for a period shorter than a full fiscal year. The document is 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Interim / Quarterly Report (IR). Q1 2020
2019-11-15 Spanish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.